Oral cancer treatment and immune targets - A role for dendritic cells?

Journal of Cranio-Maxillofacial Surgery

Volumn 40, Issue 2, 2012, Pages 103-104

  Metelmann, Hans Robert ^a   Hyckel, Peter ^a   Podmelle, Fred ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Activation of macrophage polarization; Advanced oral cavity carcinoma; Partial response to clinical treatment; Peritumoural injections of mistletoe preparation

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CYTOTOXICITY; DENDRITIC CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; KIDNEY METASTASIS; MACROPHAGE; MALE; MOUTH CARCINOMA; POLARIZATION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; KIDNEY NEOPLASMS; MACROPHAGE ACTIVATION; MALE; PHYTOTHERAPY; PLANT EXTRACTS; TONGUE NEOPLASMS; VISCUM;

EID: 84856098962     PISSN: 10105182     EISSN: 18784119     Source Type: Journal    
DOI: 10.1016/j.jcms.2011.03.009     Document Type: Article

References (13)

1. J.M. Braun, C.C. Blackwell, D.M. Weir, and J. Beuth Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA) Anticancer Res 23 2B 2003 1349 1352 (Pubitemid 36754098)
2. D.G. DeNardo, P. Andreu, and L.M. Coussens Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity Cancer Metastasis Rev 29 2 2010 309 316
3. S.R. Elluru, J.P. van Huyen, S. Delignat, M.D. Kazatchkine, A. Friboulet, and S.V. Kaveri Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer BMC Cancer 8 2008 161
4. T. Hajtó, K. Fodor, P. Perjési, and P. Németh Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine Evid Based Complement Alternat Med 2009 Nov 25 Epub
5. L. Heinzerling, V. von Baehr, C. Liebenthal, R. von Baehr, and H.D. Volk Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo J Clin Immuno 26 4 2006 347 359 (Pubitemid 44051382)
6. M.A. Horneber, G. Bueschel, R. Huber, K. Linde, and M. Rostock Mistletoe therapy in oncology Cochrane Database Syst Rev 2008 (2):CD003297
7. P. Hyckel, G. Metzner, P. Müller, and R. Quade Prognostic relevance of histologic and immunologic parameters as a contribution to the data on individualized treatment plans for carcinoma of the mouth Dtsch Z Mund Kiefer Gesichtschir 9 6 1985 475 480
8. R. Klopp, W. Schmidt, E. Werner, M. Werner, W. Niemer, and J. Beuth Influence of complementary Viscum album administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy Anticancer Res 25 1B 2005 601 610 (Pubitemid 40476103)
9. A. Mantovani, and A. Sica Macrophages, innate immunity and cancer: balance, tolerance, and diversity Curr Opin Immunol 22 2 2010 231 237
10. H.R. Metelmann, E. Wartenberg, H. Kindermann, H. Platz, and A. Scheffler Direct antineoplastic activity of different mistletoe preparations against oral cancer cells in vitro Proc AACR Clinical Investigations 33 1992 224
11. J.B. Swann, and M.J.J. Smyth Immune surveillance of tumors J Clin Invest 117 5 2007 1137 1146 (Pubitemid 46718398)
12. S. Ostrand-Rosenberg Immune surveillance: a balance between protumor and antitumor immunity Curr Opin Genet Dev 18 1 2008 8 11
13. J.M. Reiman, M. Kmieciak, M.H. Manjili, and K. Knutson Tumor immunoediting and immunosculpting pathways to cancer progression Semin Cancer Biol 17 4 June 26 2007 275 287 Epub (Pubitemid 47211962)